✦ LIBER ✦

Natural history of liver disease in cystic fibrosis

✍ Scribed by Anders Lindblad; Hans Glaumann; Birgitta Strandvik

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 166 KB
Volume: 30
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510300527

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alcoholic liver disease: Natural history

✍ Diehl, A M 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 109 KB

A lcohol consumption was identified as a risk factor for liver disease centuries ago when Laennec documented a high prevalence of cirrhosis among heavy drinkers. 1 Modern epidemiological data from many societies confirm a strong correlation between death attributable to cirrhosis and per capita cons

Reply: The utility of noninvasive imagin

Reply: The utility of noninvasive imaging in cystic fibrosis liver disease

✍ Peter J. Lewindon; Grant A. Ramm 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

Natural history of cystic disease: The i

Natural history of cystic disease: The importance of cyst type

✍ Dr. J. M. Dixon; W. N. Scott; W. R. Miller 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 1 views

Abstract All breast cysts aspirated from a series of 100 patients followed for a minimum period of 2 years were classified on the basis of electrolyte composition as apocrine or flattened, this being the nature of the epithelium lining the two populations of breast cysts. Patients with single cyst w

Immunological aspects of bronchopulmonar

Immunological aspects of bronchopulmonary disease in cystic fibrosis

✍ Bettina Hilman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for cystic fibrosis

✍ Simon Horslen; Stuart Sweet; Robert G. Gish; Ross Shepherd 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Cystic fibrosis (CF) is a multisystem disease caused by mutations in a single gene (cystic fibrosis transmembrane conductance regulator) and is the most frequent potentially fatal inherited condition in whites, occurring in 1 in 2,000 births. Progressive pulmonary disease is the major contributor to

Endogenous ursodeoxycholic acid and chol

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis

✍ Jeffery L. Smith; Peter J. Lewindon; Anita C. Hoskins; Tamara N. Pereira; Kennet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Focal biliary cirrhosis causes significant morbidity and mortality in cystic fibrosis (CF). Although the mechanisms of pathogenesis remain unclear, bile acids have been proposed as potential mediators of liver injury. This study examined bile acid composition in CF and assessed altered bile acid pro